Clifford Robinson, MD

Siteman Cancer Center/Washington University School of Medicine in St. Louis

Disclosure:
Employment
Washington University in St Louis: Assistant Professor: Employee

Compensation
DFINE: Speaker's Bureau, Travel Expenses; Elekta: Research Grants; Radialogica: Advisory Board; Varian Medical Systems: Research Grants, Speaker's Bureau, Travel Expenses

Ownership
Radialogica: Stock Options

Biography:
Dr. Cliff Robinson an Associate Professor of Radiation Oncology at Washington University in St. Louis where he serves as Chief of the Stereotactic Body Radiation Therapy (SBRT) service, and Director of Clinical Trials and Clinical Informatics. An overreaching theme to his research interests are the development and optimization of advanced radiotherapy delivery, with a particular focus on integrating and testing these methods with other specialties through collaborative, multidisciplinary clinical trials.

In his work with cardiothoracic surgery, he is PI of a trial exploring outcomes after SBRT or surgery for early stage lung cancer, including development of patient selection models and piloting a bundled-payment model across the two disciplines. Through collaborations with medical oncology, he is a co-chair on multiple national cooperative group trials exploring the safety and efficacy of SBRT as a means to improve survival for metastatic cancer, and PI of an institutional trial testing the novel combination of immunotherapy with esophageal brachytherapy to enhance immune response in metastatic esophageal cancer.

In his most recent foray outside of cancer, he has partnered with cardiology in the development of a novel, totally noninvasive treatment for arrhythmia using SBRT. In this capacity, he is co-PI of a trial exploring the safety and preliminary efficacy of this treatment for high risk patients with refractory ventricular tachycardia.

Presentation(s):

Challenges and solutions for dose accumulation and evaluation in Lung - Clinical Case
Sunday, October 21
5:02 PM – 5:19 PM
32 - Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
Sunday, October 21
5:05 PM – 5:15 PM
SS 26 - Lung 3 - Toxicity
Tuesday, October 23
2:45 PM – 4:15 PM

Send Email for Clifford Robinson

Subject

Body

<h1>  shared a speaker with you!</h1><div><b>Name:</b> Clifford Robinson</div><div><b>Organization:</b> Siteman Cancer Center/Washington University School of Medicine in St. Louis</div><div><b>Position:</b> Not Available</div><div><b>Bio:</b> Dr. Cliff Robinson an Associate Professor of Radiation Oncology at Washington University in St. Louis where he serves as Chief of the Stereotactic Body Radiation Therapy (SBRT) service, and Director of Clinical Trials and Clinical Informatics. An overreaching theme to his research interests are the development and optimization of advanced radiotherapy delivery, with a particular focus on integrating and testing these methods with other specialties through collaborative, multidisciplinary clinical trials.

In his work with cardiothoracic surgery, he is PI of a trial exploring outcomes after SBRT or surgery for early stage lung cancer, including development of patient selection models and piloting a bundled-payment model across the two disciplines. Through collaborations with medical oncology, he is a co-chair on multiple national cooperative group trials exploring the safety and efficacy of SBRT as a means to improve survival for metastatic cancer, and PI of an institutional trial testing the novel combination of immunotherapy with esophageal brachytherapy to enhance immune response in metastatic esophageal cancer.

In his most recent foray outside of cancer, he has partnered with cardiology in the development of a novel, totally noninvasive treatment for arrhythmia using SBRT. In this capacity, he is co-PI of a trial exploring the safety and preliminary efficacy of this treatment for high risk patients with refractory ventricular tachycardia.  
</div>